Status:
RECRUITING
Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry
Lead Sponsor:
Lille University
Collaborating Sponsors:
Centre Oscar Lambret, Lille, France
Conditions:
Rhabdomyosarcoma
Eligibility:
All Genders
Up to 25 years
Brief Summary
This non-interventional study aims to develop spatial proteomics for analyzing small FFPE tumor samples in rhabdomyosarcoma. It will identify molecular signatures linked to tumor regions, subtypes, su...
Detailed Description
This is a non-interventional, monocentric, retrospective cohort study aimed at developing a spatial proteomics analysis method for small tumor samples (FFPE) to precisely characterize proteins at the ...
Eligibility Criteria
Inclusion
- Age between 0 and 25 years at the time of initial diagnosis
- Diagnosis of rhabdomyosarcoma confirmed histologically
- Care at the Oscar Lambret Center between January 2005 and November 2024
- No objection to the re-use of data and biological samples collected as part of care for research activities.
Exclusion
- Unavailability of biological sample in FFPE from biopsy and/or surgical specimen for diagnosis at Centre Oscar Lambret;
- Patient under guardianship or trusteeship.
Key Trial Info
Start Date :
March 13 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06924463
Start Date
March 13 2025
End Date
February 28 2026
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oscar Lambret Center
Lille, Nord, France, 59000